These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19115486)

  • 21. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature.
    Guan C; Li J; Xu P; Ouyang J; Chen B
    Int J Clin Exp Pathol; 2015; 8(8):9629-37. PubMed ID: 26464729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.
    Javier R; Shaikh N; Lesniak MS; Sonabend A; Stupp R; Behdad A; Horbinski C
    Diagn Pathol; 2018 Jun; 13(1):37. PubMed ID: 29871654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and secondary cutaneous diffuse large B-cell lymphomas: a multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation.
    Kim BK; Surti U; Pandya AG; Swerdlow SH
    Am J Surg Pathol; 2003 Mar; 27(3):356-64. PubMed ID: 12604892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
    Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
    Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Luo XL
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):771-5. PubMed ID: 16545182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics.
    Anderson JJ; Fordham S; Overman L; Dignum H; Wood K; Proctor SJ; Crosier S; Angus B; Culpin RE; Mainou-Fowler T
    Int J Oncol; 2009 Nov; 35(5):961-71. PubMed ID: 19787248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo CD5-positive diffuse large B cell lymphoma solely presenting as multiple subcutaneous nodules.
    Takahashi T; Kazama Y; Shimizu H; Yoshimoto M; Tsujisaki M; Imai K
    Acta Haematol; 2002; 107(4):230-3. PubMed ID: 12053152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral T-cell lymphoma of Lennert type complicated by monoclonal proliferation of large B-cells.
    Chihara T; Wada N; Kohara M; Matsui T; Masaya H; Maeda T; Shibayama H; Kanakura Y; Tani M; Morii E; Aozasa K
    Pathol Res Pract; 2010 Mar; 206(3):185-90. PubMed ID: 19481878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
    Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
    Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
    Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
    Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
    Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
    J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD3-positive diffuse large B-cell lymphoma relapses as CD3-negative large B-cell lymphoma: Loss of aberrant antigen expression in B-cell lymphoma after chemotherapy.
    Yang LH; Ingersoll K; Zhao Y; Luedke C; Sebastian S; Wang E
    Pathol Res Pract; 2018 Oct; 214(10):1738-1744. PubMed ID: 30025593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: a diagnostic challenge.
    Cesinaro AM; Bettelli S; Maccio L; Milani M
    Am J Dermatopathol; 2014 Feb; 36(2):e16-8. PubMed ID: 23612032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
    Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
    Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
    Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.